Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-11

Clinical Trial Update: Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal Impedance [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Smectite as a food thickener for gastroesophageal reflux disease in neonates; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Smectite (smectite)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Gastroesophageal Reflux in Neonates | Phase 4 | Status: COMPLETED